BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26438540)

  • 1. Second primary osteosarcomas in patients with retinoblastoma.
    Fujiwara T; Fujiwara M; Numoto K; Ogura K; Yoshida A; Yonemoto T; Suzuki S; Kawai A
    Jpn J Clin Oncol; 2015 Dec; 45(12):1139-45. PubMed ID: 26438540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcome of osteosarcoma after bilateral retinoblastoma: a retrospective study of eight cases.
    Lee JA; Choi SY; Kang HJ; Lee JW; Kim H; Kim JH; Sung KW; Shin HY; Ahn HS; Park KD
    Br J Ophthalmol; 2014 Oct; 98(10):1355-9. PubMed ID: 24795337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the Clinical Presentation of Secondary Osteosarcoma in Patients Who Survive Retinoblastoma Differ From That of Conventional Osteosarcoma and How Do We Detect Them?
    Kim Y; Park JW; Cho HS; Jang WY; Han I; Kim HS
    Clin Orthop Relat Res; 2023 Nov; 481(11):2154-2163. PubMed ID: 37145140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center.
    Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Astrahantseff K; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Jöckel KH; Lohmann DR
    Pediatr Blood Cancer; 2017 Jan; 64(1):71-80. PubMed ID: 27567086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma.
    Ueda T; Koga Y; Yoshikawa H; Tanabe M; Yamana K; Oba U; Nakashima K; Ono H; Ichimura T; Hasegawa S; Kato W; Kobayashi T; Nakayama H; Sakai Y; Yoshitake T; Ohga S; Oda Y; Suzuki S; Sonoda KH; Ohga S
    BMC Pediatr; 2020 Jan; 20(1):37. PubMed ID: 31992242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Craniofacial second primary tumors in patients with germline retinoblastoma previously treated with external beam radiotherapy: A retrospective institutional analysis.
    Jiménez I; Laé M; Tanguy ML; Savignoni A; Gauthier-Villars M; Desjardins L; Cassoux N; Dendale R; Rodriguez J; Doz F; Brisse HJ; Aerts I
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28158. PubMed ID: 31904159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteosarcoma following retinoblastoma: age at onset and latency period.
    Chauveinc L; Mosseri V; Quintana E; Desjardins L; Schlienger P; Doz F; Dutrillaux B
    Ophthalmic Genet; 2001 Jun; 22(2):77-88. PubMed ID: 11449317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival in osteosarcoma patients following retinoblastoma using doxorubicin, cisplatin, and methotrexate.
    Stine KC; Saylors RL; Saccente S; Becton DL
    Med Pediatr Oncol; 2003 Jul; 41(1):77-8. PubMed ID: 12764753
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group.
    Bielack SS; Kempf-Bielack B; Heise U; Schwenzer D; Winkler K
    J Clin Oncol; 1999 Apr; 17(4):1164. PubMed ID: 10561175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transglabellar/subcranial approach for surgical excision of periocular second tumors in retinoblastoma.
    Demirci H; Marentette LJ; Nelson CC
    Orbit; 2008; 27(4):285-91. PubMed ID: 18716966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009).
    Lumbroso-Le Rouic L; Savignoni A; Levy-Gabriel C; Aerts I; Cassoux N; Salviat F; Gauthier-Villars M; Freneaux P; Brisse H; Dendale R; Esteve M; Doz F; Desjardins L
    J Fr Ophtalmol; 2015 Jun; 38(6):535-41. PubMed ID: 25976136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second cranio-facial malignancies in hereditary retinoblastoma survivors previously treated with radiation therapy: clinic and radiologic characteristics and survival outcomes.
    Rodjan F; Graaf Pd; Brisse HJ; Verbeke JI; Sanchez E; Galluzzi P; Göricke S; Maeder P; Aerts I; Dendale R; Desjardins L; de Franscesco S; Bornfeld N; Sauerwein W; Popovic MB; Knol DL; Moll AC; Castelijns JA
    Eur J Cancer; 2013 May; 49(8):1939-47. PubMed ID: 23415887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive management of second primary tumors in survivors of hereditary retinoblastoma.
    Smith LM; Donaldson SS; Egbert PR; Link MP; Bagshaw MA
    Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):499-505. PubMed ID: 2777644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of radiation-related osteosarcoma after treatment of childhood and adolescent cancer: a study of 23 cases.
    Tabone MD; Terrier P; Pacquement H; Brunat-Mentigny M; Schmitt C; Babin-Boilletot A; Mahmoud HH; Kalifa C
    J Clin Oncol; 1999 Sep; 17(9):2789-95. PubMed ID: 10561354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronous and metachronous skeletal osteosarcomas: the Norwegian Radium Hospital experience.
    Brandal P; Bjerkehagen B; Bruland OS; Skjeldal S; Bogsrud TV; Hall KS
    Acta Oncol; 2009; 48(8):1165-72. PubMed ID: 19863225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
    Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
    J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan.
    Kudawara I; Aoki Y; Ueda T; Araki N; Naka N; Nakanishi H; Matsumine A; Ieguchi M; Mori S; Myoui A; Kuratsu S; Hashimoto N; Yoshikawa H
    J Chemother; 2013 Feb; 25(1):41-8. PubMed ID: 23433444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood.
    Le Vu B; de Vathaire F; Shamsaldin A; Hawkins MM; Grimaud E; Hardiman C; Diallo I; Vassal G; Bessa E; Campbell S; Panis X; Daly-Schveitzer N; Lagrange JL; Zucker JM; Eschwège F; Chavaudra J; Lemerle J
    Int J Cancer; 1998 Jul; 77(3):370-7. PubMed ID: 9663598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of patients with a history of bilateral retinoblastoma treated for a second malignancy: the Memorial Sloan-Kettering experience.
    Dunkel IJ; Gerald WL; Rosenfield NS; Strong EW; Abramson DH; Ghavimi F
    Med Pediatr Oncol; 1998 Jan; 30(1):59-62. PubMed ID: 9371391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.